• Users Online: 698
  • Print this page
  • Email this page
Year : 2020  |  Volume : 17  |  Issue : 5  |  Page : 2-5

COVID-19 and stroke – Updated review

1 Institute of Neurosciences, Indraprastha Apollo Hospitals, Saket, New Delhi, India
2 Department of Critical Care, Max Hospital, Saket, New Delhi, India

Correspondence Address:
Pushpendra Nath Renjen
C-85, Anand Niketan, New Delhi - 110 021
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/am.am_89_20

Rights and Permissions

Although the precise incidence is not known, stroke is emerging as a complication of the COVID-19 pandemic. The clinical course of COVID-19 is most severe in elderly patients, in men, and in patients with comorbidities such as hypertension, diabetes, heart disease, and obesity, all risk factors for stroke. Severe acute respiratory syndrome coronavirus infection is linked to a prothrombotic state causing venous and arterial thromboembolism and elevated D-dimer levels. The occurrence of acute ischemic stroke at the time of this pandemic poses a great challenge regarding emergency treatment (particularly administering thrombolysis and performing thrombectomy) of acute stroke patients. In this article, we will review the pathophysiology and challenges in the management of COVID-19 infection-associated stroke.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal